Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses

Journal of Virology

Volumn 85, Issue 1, 2011, Pages 254-263

  Vali, Bahareh ^a   Tohn, Robert ^a   Cohen, Michael J ^a   Sakhdari, Ali ^a   Sheth, Prameet M ^a   Yue, Feng Yun ^a   Wong, David ^b   Kovacs, Colin ^c   Kaul, Rupert ^a,b   Ostrowski, Mario A ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c MAPLE LEAF MEDICAL CLINIC   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROTEOME;

AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; LIVER DISEASE; LYMPHOCYTE SUBPOPULATION; MIXED INFECTION; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STAINING;

AMINO ACID SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; GENE PRODUCTS, GAG; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HLA-A2 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; VIRAL NONSTRUCTURAL PROTEINS;

HEPACIVIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; ORTHOMYXOVIRIDAE;

EID: 78650069102     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01743-10     Document Type: Article

References (26)

1. Al-Mohri, H., C. Cooper, T. Murphy, and M. B. Klein. 2005. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients. HIV Med. 6:375-378.
2. Borsoi Viana, M. S., K. Takei, D. C. Collarile Yamaguti, B. Guz, and E. Strauss. 2009. Use of AST platelet ratio index (APRI score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Ann. Hepatol. 8:26-31.
3. Brehm, M. A., A. K. Pinto, K. A. Daniels, J. P. Schneck, R. M. Welsh, and L. K. Selin. 2002. T cell immunodominance and maintenance of memory regulated by unexpectedly cross-reactive pathogens. Nat. Immunol. 3:627-634.
4. Chen, W., K. A. Masterman, S. Basta, S. M. Haeryfar, N. Dimopoulos, B. Knowles, J. R. Bennink, and J. W. Yewdell. 2004. Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon. Eur. J. Immunol. 34:194-199.
5. Clute, S. C., L. B. Watkin, M. Cornberg, Y. N. Naumov, J. L. Sullivan, K. Luzuriaga, R. M. Welsh, and L. K. Selin. 2005. Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis. J. Clin. Invest. 115:3602-3612.
6. Fazekas de St. Groth and R. G. Webster. 1966. Disquisitions of original antigenic sin. I. Evidence in man. J. Exp. Med. 124:331-345.
7. Goulder, P. J., M. A. Altfeld, E. S. Rosenberg, T. Nguyen, Y. Tang, R. L. Eldridge, M. M. Addo, S. He, J. S. Mukherjee, M. N. Phillips, M. Bunce, S. A. Kalams, R. P. Sekaly, B. D. Walker, and C. Brander. 2001. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193:181-194.
8. Graham, C. S., L. R. Baden, E. Yu, J. M. Mrus, J. Carnie, T. Heeren, and M. J. Koziel. 2001. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin. Infect. Dis. 33:562-569.
9. Kasprowicz, V., S. M. Ward, A. Turner, A. Grammatikos, B. E. Nolan, L. Lewis-Ximenez, C. Sharp, J. Woodruff, V. M. Fleming, S. Sims, B. D. Walker, A. K. Sewell, G. M. Lauer, and P. Klenerman. 2008. Defining the directionality and quality of influenza virus-specific CD8+ T cell crossreactivity in individuals infected with hepatitis C virus. J. Clin. Invest. 118: 1143-1153.
10. Klenerman, P., and R. M. Zinkernagel. 1998. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394:482-485.
11. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499-1512.
12. Nunes, D., C. Fleming, G. Offner, D. Craven, O. Fix, T. Heeren, M. J. Koziel, C. Graham, S. Tumilty, P. Skolnik, S. Stuver, C. Robert Horsburgh, Jr., and D. Cotton. 2010. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am. J. Gastroenterol. 105:1346-1353.
13. Selin, L. K., M. A. Brehm, Y. N. Naumov, M. Cornberg, S. K. Kim, S. C. Clute, and R. M. Welsh. 2006. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol. Rev. 211:164-181.
14. Selin, L. K., M. Y. Lin, K. A. Kraemer, D. M. Pardoll, J. P. Schneck, S. M. Varga, P. A. Santolucito, A. K. Pinto, and R. M. Welsh. 1999. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11:733-742.
15. Selin, L. K., S. R. Nahill, and R. M. Welsh. 1994. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 179:1933-1943.
16. Selin, L. K., S. M. Varga, I. C. Wong, and R. M. Welsh. 1998. Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 188:1705-1715.
17. Shastry, L., T. Wilson, S. Lascher, and J. A. Nord. 2007. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients. AIDS 21:2541-2543.
18. Sheth, P. M., S. Sunderji, L. Y. Shin, A. Rebbapragada, S. Huibner, J. Kimani, K. S. Macdonald, E. Ngugi, J. J. Bwayo, S. Moses, C. Kovacs, M. Loutfy, and R. Kaul. 2008. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J. Infect. Dis. 197:1394-1401.
19. Thein, H. H., Q. Yi, G. J. Dore, and M. D. Krahn. 2008. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS 22:1979-1991.
20. Townsend, A. R., J. Rothbard, F. M. Gotch, G. Bahadur, D. Wraith, and A. J. McMichael. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959-968.
21. Urbani, S., B. Amadei, P. Fisicaro, M. Pilli, G. Missale, A. Bertoletti, and C. Ferrari. 2005. Heterologous T cell immunity in severe hepatitis C virus infection. J. Exp. Med. 201:675-680.
22. Vali, B., F. Y. Yue, R. B. Jones, P. M. Sheth, R. Kaul, M. R. Betts, D. Wong, C. Kovacs, M. Loutfy, A. Common, R. Halpenny, and M. A. Ostrowski. 2008. HIV-specific T-cells accumulate in the liver in HCV/HIV infection. PLoS One 3:e3454.
23. Wai, C. T., J. K. Greenson, R. J. Fontana, J. D. Kalbfleisch, J. A. Marrero, H. S. Conjeevaram, and A. S. Lok. 2003. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518-526.
24. Wedemeyer, H., E. Mizukoshi, A. R. Davis, J. R. Bennink, and B. Rehermann. 2001. Cross-reactivity between hepatitis C virus and influenza A virus determinant-specific cytotoxic T cells. J. Virol. 75:11392-11400. (Pubitemid 33063230)
25. Welsh, R. M., and L. K. Selin. 2002. No one is naive: the significance of heterologous T-cell immunity. Nat. Rev. Immunol. 2:417-426.
26. Yin, Y., and R. A. Mariuzza. 2009. The multiple mechanisms of T cell receptor cross-reactivity. Immunity 31:849-851.